Return-Path: <contact@fiidewgal.com>
Delivered-To: contact@fiidewgal.com
Received: from node187-eu.n0c.com
	by node187-eu.n0c.com with LMTP
	id 2L2pA1J5gmRtFicA3R2AvA
	(envelope-from <contact@fiidewgal.com>)
	for <contact@fiidewgal.com>; Fri, 09 Jun 2023 02:58:58 +0200
X-Spam-Status: No
DKIM-Filter: OpenDKIM Filter v2.11.0 mailfilter-eu.n0c.com 4QcjQ91WwBz34SDmn
Authentication-Results: mailfilter-eu.n0c.com;
	dkim=pass (1024-bit key) header.d=fiidewgal.com header.i=@fiidewgal.com header.b="hQ616Z89"
X-N0C-MailScanner-eFa-Watermark: 1686877083.64759@6T/pZqW2CR151Tk5+VKQ9g
X-N0C-MailScanner-eFa-From: contact@fiidewgal.com
X-N0C-MailScanner-eFa: Please contact report@N0C.info for details
X-N0C-MailScanner-eFa-ID: 9A66B4019B0A.A9485
X-N0C-MailScanner-eFa-Information: Please contact N0C for more information
Received: from fiidewgal.com ([185.221.182.45] [185.221.182.45])
	(using TLSv1.3 with cipher TLS_AES_256_GCM_SHA384 (256/256 bits))
	(no client certificate requested)	(Authenticated sender: contact@fiidewgal.com)
	by mailfilter-eu.n0c.com (MailScanner Milter) with SMTP id 9A66B4019B0A
	for <contact@fiidewgal.com>; Fri,  9 Jun 2023 02:58:02 +0200 (CEST)
DMARC-Filter: OpenDMARC Filter v1.4.1 node187-eu.n0c.com 9A66B4019B0A
Authentication-Results: node187-eu.n0c.com; dmarc=pass (p=none dis=none) header.from=fiidewgal.com
Authentication-Results: node187-eu.n0c.com; spf=pass smtp.mailfrom=fiidewgal.com
DKIM-Filter: OpenDKIM Filter v2.11.0 node187-eu.n0c.com 9A66B4019B0A
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=fiidewgal.com;
	s=default; t=1686272282;
	bh=TkfDfCnYZcpyZeexOyEXFDgW6IfA+X92fGB1IzHgNA8=;
	h=Date:Subject:From:To:From;
	b=hQ616Z89Wl4qneKoPYChAAmWCqhB31O21/lsLXhxJ/HgJs1fOrRJKsyTRqGPLq0cu
	 m3Y7XYCGdAGorvTLLKBHOH/9oT9pUM+uG+xuxJq1HQ83sxfBcmueQzIZMrR4XaEcr2
	 D6J1icpZS5z2pixFoGX5bl9G9aK4CNOEAImjeAMI=
Message-ID: <f4a2600d7bc01744c69f897de60cb185@fiidewgal.com>
Date: Fri, 09 Jun 2023 02:58:02 +0200
Subject: CLJ PHARMA Service - Business Proposal
From: Ne =?utf-8?Q?r=C3=A9pondez?= pas <contact@fiidewgal.com>
To: contact@fiidewgal.com
MIME-Version: 1.0
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: quoted-printable
X-N0C-Node-IP: 185.221.182.45

Greetings,=20
=20
I am a research consultant working with a leading laboratory in the United =
Kingdom. Our company, CLJ PHARMA, is a highly respected and successful phar=
ma manufacturer. We produce a wide range of life-saving biopharmaceutical p=
roducts and medical consumables.=20
=20
I have an exciting business proposal to share with you. If you're intereste=
d, please contact me at  anthony_breiner@drbreiner.com. You have the option=
 to decline after hearing the details, but I assure you won't regret consid=
ering this opportunity.=20
=20
Looking forward to your positive response.=20
=20
Regards,=20
Dr. Anthony

